DE602004017439D1 - Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten - Google Patents
Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheitenInfo
- Publication number
- DE602004017439D1 DE602004017439D1 DE602004017439T DE602004017439T DE602004017439D1 DE 602004017439 D1 DE602004017439 D1 DE 602004017439D1 DE 602004017439 T DE602004017439 T DE 602004017439T DE 602004017439 T DE602004017439 T DE 602004017439T DE 602004017439 D1 DE602004017439 D1 DE 602004017439D1
- Authority
- DE
- Germany
- Prior art keywords
- disorders
- diseases
- diagnostic
- receptor
- associated diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 3
- 201000010099 disease Diseases 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000002560 therapeutic procedure Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 208000018522 Gastrointestinal disease Diseases 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 2
- 201000011510 cancer Diseases 0.000 abstract 2
- 208000035475 disorder Diseases 0.000 abstract 2
- 230000002496 gastric effect Effects 0.000 abstract 2
- 208000014951 hematologic disease Diseases 0.000 abstract 2
- 208000027866 inflammatory disease Diseases 0.000 abstract 2
- 208000019423 liver disease Diseases 0.000 abstract 2
- 208000023504 respiratory system disease Diseases 0.000 abstract 2
- 208000014001 urinary system disease Diseases 0.000 abstract 2
- 101150009981 C5AR1 gene Proteins 0.000 abstract 1
- 102100032957 C5a anaphylatoxin chemotactic receptor 1 Human genes 0.000 abstract 1
- 101000867983 Homo sapiens C5a anaphylatoxin chemotactic receptor 1 Proteins 0.000 abstract 1
- 238000003556 assay Methods 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 102000056190 human C5AR1 Human genes 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Rehabilitation Therapy (AREA)
- Biotechnology (AREA)
- Rheumatology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03005467 | 2003-03-17 | ||
| PCT/EP2004/002175 WO2004082568A2 (en) | 2003-03-17 | 2004-03-04 | Diagnostics and therapeutics for diseases associated with complement component 5a receptor (c5ar) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE602004017439D1 true DE602004017439D1 (de) | 2008-12-11 |
Family
ID=33016821
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE602004017439T Expired - Lifetime DE602004017439D1 (de) | 2003-03-17 | 2004-03-04 | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060240436A1 (de) |
| EP (1) | EP1606621B1 (de) |
| AT (1) | ATE412903T1 (de) |
| DE (1) | DE602004017439D1 (de) |
| ES (1) | ES2314383T3 (de) |
| WO (1) | WO2004082568A2 (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007501605A (ja) * | 2003-08-08 | 2007-02-01 | ジェノバ・リミテッド | 心血管疾患に関連する分泌ポリペプチド種 |
| ES2587344T3 (es) * | 2003-12-24 | 2016-10-24 | Novo Nordisk A/S | Ratón transgénico que comprende un polinucleótido que codifica C5aR humano o humanizado |
| DK2718322T3 (en) | 2011-06-06 | 2018-12-03 | Novo Nordisk As | THERAPEUTIC ANTIBODIES |
| EP3349773A4 (de) * | 2015-09-14 | 2019-05-01 | Cincinnati Children's Hospital Medical Center | Verfahren und zusammensetzungen zur behandlung der gaucher-krankheit durch modulation des c5a-rezeptors |
| TW202140553A (zh) | 2020-01-13 | 2021-11-01 | 美商威特拉公司 | C5ar1抗體分子及其用途 |
| CA3173944A1 (en) | 2021-01-13 | 2022-07-21 | Visterra, Inc. | Humanized complement 5a receptor 1 antibodies and methods of use thereof |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5614370A (en) * | 1994-03-18 | 1997-03-25 | Merck & Co., Inc. | Assay to identify human C5a antagonists and agonists |
| US5861272A (en) * | 1995-06-02 | 1999-01-19 | Human Genome Sciences, Inc. | C5A receptor |
| KR100884709B1 (ko) * | 2000-09-14 | 2009-02-19 | 미쓰비시 타나베 파마 코퍼레이션 | 신규한 아미드 유도체의 광학 활성체 및 그의 의약적 용도 |
-
2004
- 2004-03-04 AT AT04717062T patent/ATE412903T1/de not_active IP Right Cessation
- 2004-03-04 WO PCT/EP2004/002175 patent/WO2004082568A2/en active Application Filing
- 2004-03-04 EP EP04717062A patent/EP1606621B1/de not_active Expired - Lifetime
- 2004-03-04 DE DE602004017439T patent/DE602004017439D1/de not_active Expired - Lifetime
- 2004-03-04 ES ES04717062T patent/ES2314383T3/es not_active Expired - Lifetime
- 2004-03-04 US US10/548,962 patent/US20060240436A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1606621B1 (de) | 2008-10-29 |
| EP1606621A2 (de) | 2005-12-21 |
| US20060240436A1 (en) | 2006-10-26 |
| WO2004082568A2 (en) | 2004-09-30 |
| WO2004082568A3 (en) | 2005-01-13 |
| ATE412903T1 (de) | 2008-11-15 |
| ES2314383T3 (es) | 2009-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2004104216A3 (en) | Diagnostics and therapeutics for diseases associated with dipeptidylpeptidase iv (dpp4) | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| DE602004017439D1 (de) | Diagnostik- und therapie- verfahren von mit c5a rezeptor verbundenen krankheiten | |
| WO2005103702A3 (en) | Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 2 (cxcr2) | |
| WO2005078117A3 (en) | Diagnostics and therapeutics for diseases associated with kallikrein 6 (klk6) | |
| WO2005085466A3 (en) | Diagnostic and therapeutics for diseases associated with rho-associated protein kinase 2 (rock2) | |
| WO2004097358A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 2 (tmprss2) | |
| WO2005075675A3 (en) | Diagnostics and therapeutics for diseases associated with putative cysteine protease 1 (prs1) | |
| WO2005106488A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled beta-2 adrenoceptor (adrb2) | |
| DE602004014261D1 (de) | Diagnostik- und therapie- verfahren von mit dopaminrezeptor d3 (drd3) verbundenen krankheiten | |
| WO2004104574A3 (en) | Diagnostics and therapeutics for diseases associated with c-c chemokine receptor type 7 (ccr7) | |
| ATE554393T1 (de) | Diagnostika und therapeutika für mit adiponectin receptor 2 (adipor2) assoziierten erkrankungen | |
| DE602004014254D1 (de) | Diagnostik- und therapie- verfahren von mit 5-ht1f rezeptor verbundenen haematologischen krankheiten | |
| WO2004080374A3 (en) | Diagnostics and therapeutics for diseases associated with phosphodi-esterase 1c (pde1c) | |
| DE602004013770D1 (de) | Diagnostik- und therapie- verfahren von mit pils verbundenen krankheiten | |
| WO2005085469A3 (en) | Diagnostics and therapeutics for diseases associated with rho-associated protein kinase 1 (rock1) | |
| WO2005040211A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 1 (gpr1) | |
| WO2007141005A8 (en) | Use of glutamyl aminopeptidase (enpep) as a therapeutic or diagnostic target | |
| WO2006013013A3 (en) | Diagnostics and therapeutics for diseases associated with protective protein for beta-galactosidase (ppgb) | |
| WO2005103711A3 (en) | Diagnostics and therapeutics for diseases associated with cxc chemokine receptor 1 (cxcr1) | |
| WO2004082571A3 (en) | Diagnostics and therapeutics for diseases associated with g protein-coupled receptor 86 (gpr86) | |
| WO2004099248A3 (en) | Diagnostics and therapeutics for diseases associated with g-protein-coupled receptor agtr2 (agtr2) | |
| WO2004097034A3 (en) | Diagnostics and therapeutics for diseases associated with human transmembrane serine protease 4 (tmprss4) | |
| WO2004104595A3 (en) | Diagnostics and therapeutics for diseases associated with x-pro dipeptidase (pepd) | |
| WO2005026719A3 (en) | Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8327 | Change in the person/name/address of the patent owner |
Owner name: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT, 1335, DE |
|
| 8364 | No opposition during term of opposition |